Combretol is primarily used in research settings for its potential anticancer properties. It has shown activity in inhibiting the growth of certain tumor cell lines by interfering with microtubule dynamics, which disrupts cell division. This makes it a subject of interest in the development of chemotherapeutic agents. Additionally, Combretol serves as a structural analog in the synthesis of more stable or potent derivatives, especially in studies focused on natural product-based drug discovery. Its role in apoptosis induction and cell cycle arrest further supports its investigation in oncology-related research.